In a new study, scientists have identified a small molecule candidate drug that triggers the formation of left-handed Z-DNA in cells that in turn activates a highly immunogenic programmed pathway of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback